Comparative Effects of Mirror Therapy and Cognitive Orientation to Daily Occupational Performance… (NCT07546864) | Clinical Trial Compass
RecruitingNot Applicable
Comparative Effects of Mirror Therapy and Cognitive Orientation to Daily Occupational Performance in Stroke: A Randomized Controlled Trial
Turkey (Türkiye)45 participantsStarted 2026-02-15
Plain-language summary
This study aims to compare the effectiveness of three rehabilitation approaches in individuals with stroke: mirror therapy (MT), cognitive orientation to daily occupational performance (CO-OP), and conventional occupational therapy (COT), all combined with robotic balance training.
A total of 45 individuals with subacute and chronic stroke will be randomly assigned to one of three groups. Each group will receive 4 weeks of intervention (5 sessions per week), followed by a 3-month follow-up period.
Outcomes related to motor function, somatosensory function, activities of daily living, participation, and quality of life will be assessed at baseline, after intervention, and at follow-up.
The study aims to determine which intervention approach is more effective in improving functional outcomes in individuals with stroke.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* \- Individuals diagnosed with ischemic or hemorrhagic stroke
* Age 18 years and older
* Subacute (3-6 months post-stroke) or chronic stage (6-12 months post-stroke)
* Brunnstrom Motor Recovery Stage ≥3 for upper extremity, ≥4 for hand, and ≥4 for lower extremity
* Mini-Mental State Examination (MMSE) score ≥24
* No severe visual, orthopedic, or additional neurological impairments
* Not participating in another study during the research period
* Voluntary consent to participate in the study
Exclusion Criteria:
* \- Poor motor coordination or major medical problems that would prevent participation
* Presence of Wernicke's aphasia
* Botulinum toxin injection within the last 3 months
* Psychiatric conditions that may interfere with participation (e.g., depression, ongoing psychiatric treatment, low motivation)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Fugl-Meyer Motor Assessment (FMA)
Timeframe: Baseline, post-intervention (4 weeks), and 3-month follow-up